Page last updated: 2024-10-29

amrinone and Bone Loss, Osteoclastic

amrinone has been researched along with Bone Loss, Osteoclastic in 2 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Because stimulated bone resorption has been proposed to require Na-Ca exchange, we examined the effects of amrinone on bone."1.26Interaction between amrinone and parathyroid hormone on bone in culture. ( Krieger, NS; Stern, PH, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krieger, NS2
Stern, PH2
Stathopoulos, VM1

Other Studies

2 other studies available for amrinone and Bone Loss, Osteoclastic

ArticleYear
Interaction between amrinone and parathyroid hormone on bone in culture.
    The American journal of physiology, 1982, Volume: 243, Issue:6

    Topics: Aminopyridines; Amrinone; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcitonin; Ca

1982
Does amrinone inhibition of stimulated bone resorption involve Na+-Ca++ exchange?
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: Aminopyridines; Amrinone; Animals; Bone Resorption; Calcium; Cardiotonic Agents; Cycloheximide; Dact

1986